An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP).
about
An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
An Open-Label Study of the Lon ...... ic Pulmonary Fibrosis (RECAP).
@en
An Open-Label Study of the Lon ...... Idiopathic Pulmonary Fibrosis
@nl
type
label
An Open-Label Study of the Lon ...... ic Pulmonary Fibrosis (RECAP).
@en
An Open-Label Study of the Lon ...... Idiopathic Pulmonary Fibrosis
@nl
prefLabel
An Open-Label Study of the Lon ...... ic Pulmonary Fibrosis (RECAP).
@en
An Open-Label Study of the Lon ...... Idiopathic Pulmonary Fibrosis
@nl
P2093
P2860
P356
P1433
P1476
An Open-Label Study of the Lon ...... ic Pulmonary Fibrosis (RECAP).
@en
P2093
Carlo Albera
Chin-Yu Lin
Henry N Hulter
Lisa H Lancaster
Paul W Noble
Philip Hormel
P2860
P304
P356
10.1159/000479976
P577
2017-09-13T00:00:00Z